Tech Company Financing Transactions

Groove Biopharma Funding Round

Groove Biopharma, operating out of Seattle, secured $6 million in investment from Allegis Capital, Arch Venture Partners and OVP Venture Partners.

Transaction Overview

Company Name
Announced On
12/12/2011
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Proceeds Purpose
The money is expected to run through the end of 2012, as Groove looks to select its lead drug candidates that it believes can make it through the final preclinical studies needed before the FDA will allow clinical trials to begin.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. East 202
Seattle, WA 98102
USA
Email Address
Not Recorded
Overview
Network Solutions - Original domain name registration and reservation services with variety of internet-related business offerings. Quick, dependable and reliable.
Profile
Groove Biopharma LinkedIn Company Profile
Social Media
Groove Biopharma Company Twitter Account
Company News
Groove Biopharma News
Facebook
Groove Biopharma on Facebook
YouTube
Groove Biopharma on YouTube

Management Team

Title
Name
Email & Social
President
David McElligott
  David McElligott LinkedIn Profile  David McElligott Twitter Account  David McElligott News  David McElligott on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/12/2011: Xeris Pharmaceuticals venture capital transaction
Next: 12/12/2011: CeNeRx BioPharma venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary